CD8A and neoplasm: Whereas the ABv+IgG-treated tumors displayed reduction in active CD8+ cytotoxic T cells and minor changes in other lymphocyte subsets, the biopsied sample from ABv+anti-PD-1-treated tumor showed a general increase in the number of TILs and activity markers (Fig. 7f).